Influence of cardioprotectors mildronate and trimetazidine on MB-creatinkinase activity in stable angina patients after coronary bypass surgery
About the Authors
I. G. Gordeev
Российский государственный медицинский университет
Russian Federation
Russian Federation
E. E. Ilyina
Российский государственный медицинский университет
Russian Federation
Russian Federation
V. A. Lusov
Российский государственный медицинский университет
Russian Federation
Russian Federation
N. A. Volov
Российский государственный медицинский университет
Russian Federation
Russian Federation
E. A. Bekchiu
Российский государственный медицинский университет
Russian Federation
Russian Federation
References
1. Биленко М.В. Ишемические и реперфузионные повреждения органов. М.: Медицина, 1989, с.102-127.
2. Jesse E.A., Miracle V.A. Cardiac biomarkers: Past, Present and Future//Am. J. Critical Care, 1998, Vol.7, No.6, p.418-423.
3. Owen A. Tracking the rise and fall of cardiac enzymes//Nursing., 1995, 25(5): 35-38. 5.
4. Panteghini M., Cuccia C., Calarco M. et al. Serum enzymes in acute myocardial infarction after intracoronary thrombolysis//Clinical Biochemistry, 1986, 19:294-297.
5. Szasz G., Gruber W., Bernt E. Creatine kinase in serum: 1. Determination of optimum reaction conditions//Clin. Chem. 1976 22: 650-656.
Review
For citations:
Gordeev I.G., Ilyina E.E., Lusov V.A., Volov N.A., Bekchiu E.A. Influence of cardioprotectors mildronate and trimetazidine on MB-creatinkinase activity in stable angina patients after coronary bypass surgery. Russian Journal of Cardiology. 2004;(6):78-79. (In Russ.)
Views:
459
Email this article 